Home
SPRO
SPRO News

Latest Spero Therapeutics Inc. (SPRO) News on February 22, 2025

Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know

Zacks

a month ago

Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

GlobeNewswire

a month ago

Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

Zacks

2 months ago

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Zacks

2 months ago

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA

Neumora Stock Hits Record Low on Depression Drug Study Failure

Zacks

2 months ago

Neumora Stock Hits Record Low on Depression Drug Study Failure

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

Zacks

2 months ago

EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study

Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

2 months ago

Spero Therapeutics (SPRO) Loses -9.32% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

Zacks

2 months ago

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday

JANX Stock Hits Record High on Prostate Cancer Study Data

Zacks

3 months ago

JANX Stock Hits Record High on Prostate Cancer Study Data

PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy

Zacks

3 months ago

PTCT Stock Soars on Licensing Deal With NVS for Huntington's Therapy

Grifols Stock Declines After Brookfield Drops Buyout Offer

Zacks

3 months ago

Grifols Stock Declines After Brookfield Drops Buyout Offer

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

Zacks

3 months ago

JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

Zacks

3 months ago

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%

FATE Presents Encourgaing Data From Lupus Study, Stock Gains

Zacks

3 months ago

FATE Presents Encourgaing Data From Lupus Study, Stock Gains

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

Zacks

3 months ago

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

TenNor’s Phase III antibiotic trial meets all primary endpoints

Clinical Trials Arena

3 months ago

TenNor’s Phase III antibiotic trial meets all primary endpoints

CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC

Zacks

3 months ago

CHMP Endorses J&J's Rybrevant-Lazcluze Combo for Use in NSCLC

Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Spero Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue Estimates

Zacks

3 months ago

Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Lags Revenue Estimates

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire

3 months ago

Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update

What To Expect From Spero Therapeutics Inc (SPRO) Q3 2024 Earnings

GuruFocus.com

3 months ago

What To Expect From Spero Therapeutics Inc (SPRO) Q3 2024 Earnings

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

GlobeNewswire

3 months ago

Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

Zacks

4 months ago

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates

Zacks

4 months ago

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates

Spero’s stock slides after antibiotic flops in Phase II trial

Pharmaceutical Technology

4 months ago

Spero’s stock slides after antibiotic flops in Phase II trial

MT Newswires

4 months ago

Spero Therapeutics Suspends Program for Pulmonary Disease Drug; Plans to Cut Workforce by 39%

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

GlobeNewswire

4 months ago

Spero Therapeutics Announces SPR720 Phase 2a Interim Results and Provides a Business Update

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.

4 months ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

GlobeNewswire

4 months ago

Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024

MT Newswires

5 months ago

Spero Therapeutics Phase 1 Trial of Lung Disease Treatment Backs Further Assessment

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

GlobeNewswire

5 months ago

Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy

Spero Therapeutics to Present at Upcoming September Investor Conferences

GlobeNewswire

6 months ago

Spero Therapeutics to Present at Upcoming September Investor Conferences

Spero Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Spero Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

7 months ago

Q2 2024 Spero Therapeutics Inc Earnings Call

Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Tops Revenue Estimates

Zacks

7 months ago

Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Tops Revenue Estimates

Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024

GlobeNewswire

7 months ago

Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

Zacks

8 months ago

Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

9 months ago

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference

GlobeNewswire

9 months ago

Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

GlobeNewswire

9 months ago

Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update

Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago

Simply Wall St.

9 months ago

Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024

GlobeNewswire

9 months ago

Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

10 months ago

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14 Cheap Penny Stocks to Buy According to Analysts

Insider Monkey

10 months ago

14 Cheap Penny Stocks to Buy According to Analysts

Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.

a year ago

Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript

Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.

a year ago

Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Thomson Reuters StreetEvents

a year ago

Q4 2023 Spero Therapeutics Inc Earnings Call

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates

Zacks

a year ago

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates

Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

GlobeNewswire

a year ago

Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire

a year ago

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

GlobeNewswire

a year ago

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference

GlobeNewswire

a year ago

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference

Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares

GuruFocus.com

a year ago

Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

Simply Wall St.

a year ago

Quest Resource Holding Corporation's (NASDAQ:QRHC) top owners are retail investors with 36% stake, while 21% is held by institutions

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Insider Monkey

a year ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

Dow Jones Futures: Microsoft, Apple Lead Earnings Tsunami; What To Do Now

Investor's Business Daily

a year ago

Dow Jones Futures: Microsoft, Apple Lead Earnings Tsunami; What To Do Now

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Zacks

a year ago

Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

PR Newswire

a year ago

Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.

Bright Health Group, Inc.'s (NYSE:BHG) largest shareholders are private equity firms who were rewarded as market cap surged US$33m last week

Simply Wall St.

a year ago

Bright Health Group, Inc.'s (NYSE:BHG) largest shareholders are private equity firms who were rewarded as market cap surged US$33m last week

11 Hyper-Growth Stocks Billionaires Are Loading Up On

Insider Monkey

a year ago

11 Hyper-Growth Stocks Billionaires Are Loading Up On

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

PR Newswire

a year ago

Xiao-I (NASDAQ: AIXI) and ABB (SIX: ABBN) Forge Strategic Partnership to Drive Industrial Digital Intelligence Advancement with Hua Zang Universal Large Language Model

Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run?

Zacks

a year ago

Virco Manufacturing Corporation (VIRC) Hits Fresh High: Is There Still Room to Run?

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

StockStory

a year ago

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

Chuck Royce Increases Stake in Intevac Inc

GuruFocus.com

a year ago

Chuck Royce Increases Stake in Intevac Inc

Red Robin (RRGB) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

a year ago

Red Robin (RRGB) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Small Cap Research

a year ago

AIXI: Initiating Coverage – The AI hype cycle subsides but opportunities and challenges lie ahead in 2024

SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7

Business Wire

a year ago

SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

Business Wire

a year ago

D-Wave Announces 1,200+ Qubit Advantage2™ Prototype in New, Lower-Noise Fabrication Stack, Demonstrating 20x Faster Time-to-Solution on Important Class of Hard Optimization Problems

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

StockStory

a year ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?

Simply Wall St.

a year ago

Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?

Thomson Reuters StreetEvents

a year ago

Q4 2023 Five Point Holdings LLC Earnings Call

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

GlobeNewswire

a year ago

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

Five Point Holdings LLC Reports Robust Earnings Amid Economic Challenges

GuruFocus.com

a year ago

Five Point Holdings LLC Reports Robust Earnings Amid Economic Challenges

Bright Health rebrands as NeueHealth, distances itself from insurance portfolio

Healthcare Dive

a year ago

Bright Health rebrands as NeueHealth, distances itself from insurance portfolio

4 Stocks to Buy as Manufacturing Activity Makes Steady Progress

Zacks

a year ago

4 Stocks to Buy as Manufacturing Activity Makes Steady Progress

American Lithium Announces Financial and Operating Highlights for Third Quarter Ended November 30, 2023

GlobeNewswire

a year ago

American Lithium Announces Financial and Operating Highlights for Third Quarter Ended November 30, 2023

With 51% ownership of the shares, The Joint Corp. (NASDAQ:JYNT) is heavily dominated by institutional owners

Simply Wall St.

a year ago

With 51% ownership of the shares, The Joint Corp. (NASDAQ:JYNT) is heavily dominated by institutional owners

Here's Why You Should Hold Zebra (ZBRA) in Your Portfolio

Zacks

a year ago

Here's Why You Should Hold Zebra (ZBRA) in Your Portfolio

Alico, Inc. to Present at Sidoti Virtual Investor Conference

GlobeNewswire

a year ago

Alico, Inc. to Present at Sidoti Virtual Investor Conference

Is BTCS Inc. (BTCS) Outperforming Other Finance Stocks This Year?

Zacks

a year ago

Is BTCS Inc. (BTCS) Outperforming Other Finance Stocks This Year?

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem

ACCESSWIRE

a year ago

Xiao-I and eRoad Forge Strategic Partnership to Drive Commercialization Through Xiao-I's Hua Zang Ecosystem

Business Wire

a year ago

Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155

Best Momentum Stocks to Buy for January 8th

Zacks

a year ago

Best Momentum Stocks to Buy for January 8th

Snap-on (SNA) Looks Well Placed on RCI Initiative & Cost Plans

Zacks

a year ago

Snap-on (SNA) Looks Well Placed on RCI Initiative & Cost Plans

AlphaTime Acquisition Corp Announces Entering into a Merger Agreement with HCYC Group Company Limited

GlobeNewswire

a year ago

AlphaTime Acquisition Corp Announces Entering into a Merger Agreement with HCYC Group Company Limited

Spero Therapeutics Provides Corporate Update and 2024 Outlook

GlobeNewswire

a year ago

Spero Therapeutics Provides Corporate Update and 2024 Outlook

Why Novo Nordisk Stock Crushed the Market Today

Motley Fool

a year ago

Why Novo Nordisk Stock Crushed the Market Today

Business Wire

a year ago

Seres Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Is HomeStreet (HMST) Stock Undervalued Right Now?

Zacks

a year ago

Is HomeStreet (HMST) Stock Undervalued Right Now?

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024

Business Wire

a year ago

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

GlobeNewswire

a year ago

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION

PR Newswire

a year ago

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION

CNW Group

a year ago

GALIANO GOLD CONSOLIDATES OWNERSHIP OF THE ASANKO GOLD MINE IN TRANSFORMATIONAL TRANSACTION

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Save the Date: LuxUrban Hotels to Host Investor Day on February 6, 2024

Business Wire

a year ago

Save the Date: LuxUrban Hotels to Host Investor Day on February 6, 2024

Life Science Investor Forum: Presentations Now Available for Online Viewing

GlobeNewswire

a year ago

Life Science Investor Forum: Presentations Now Available for Online Viewing

Hedge funds investors have a lot riding on FitLife Brands, Inc. (NASDAQ:FTLF) with 45% ownership

Simply Wall St.

a year ago

Hedge funds investors have a lot riding on FitLife Brands, Inc. (NASDAQ:FTLF) with 45% ownership

Share on Social Networks: